- Home
- DNTH vs HTB Comparison
DNTH vs HTB Comparison
Compare DNTH & HTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNTH
- HTB
- Stock Information
- Founded
- DNTH 2015
- HTB 1926
- Country
- DNTH United States
- HTB United States
- Employees
- DNTH N/A
- HTB N/A
- Industry
- DNTH Biotechnology: Pharmaceutical Preparations
- HTB
- Sector
- DNTH Health Care
- HTB
- Exchange
- DNTH Nasdaq
- HTB NYSE
- Market Cap
- DNTH 606.2M
- HTB 656.5M
- IPO Year
- DNTH N/A
- HTB N/A
- Fundamental
- Price
- DNTH $21.50
- HTB $40.63
- Analyst Decision
- DNTH Strong Buy
- HTB Buy
- Analyst Count
- DNTH 8
- HTB 2
- Target Price
- DNTH $53.00
- HTB $44.00
- AVG Volume (30 Days)
- DNTH 387.8K
- HTB 58.0K
- Earning Date
- DNTH 08-07-2025
- HTB 07-22-2025
- Dividend Yield
- DNTH N/A
- HTB 1.16%
- EPS Growth
- DNTH N/A
- HTB N/A
- EPS
- DNTH N/A
- HTB 3.43
- Revenue
- DNTH $6,524,000.00
- HTB $201,616,000.00
- Revenue This Year
- DNTH N/A
- HTB $6.54
- Revenue Next Year
- DNTH N/A
- HTB $1.75
- P/E Ratio
- DNTH N/A
- HTB $12.02
- Revenue Growth
- DNTH 102.36
- HTB 7.08
- 52 Week Low
- DNTH $13.37
- HTB $30.95
- 52 Week High
- DNTH $32.27
- HTB $41.78
- Technical
- Relative Strength Index (RSI)
- DNTH 61.73
- HTB N/A
- Support Level
- DNTH $19.90
- HTB N/A
- Resistance Level
- DNTH $22.49
- HTB N/A
- Average True Range (ATR)
- DNTH 1.43
- HTB 0.00
- MACD
- DNTH 0.22
- HTB 0.00
- Stochastic Oscillator
- DNTH 64.11
- HTB 0.00
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About HTB HOMETRUST BANCSHARES INC
HomeTrust Bancshares Inc operates as a bank holding company. It engaged in the business of planning, directing and coordinating the business activities of the Bank. The Bank is a North Carolina state chartered bank and provides a range of retail and commercial banking products. Company's principal business consists of attracting deposits from the general public and investing those funds, along with borrowed funds, in commercial real estate loans, construction and development loans, commercial and industrial loans, equipment finance leases, municipal leases, loans secured by first and second mortgages on one-to-four family residences including home equity loans and other consumer loans.